Michael M.B. Hoffman's most recent trade in Annovis Bio Inc was a trade of 30,000 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on Dec. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.34 per share. | 08 Dec 2025 | 30,000 | 2,559,739 (39%) | 0% | 4.3 | 130,194 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 08 Dec 2025 | 15,000 | 2,574,739 (39%) | 0% | 4.2 | 63,600 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 24 Nov 2025 | 28,096 | 2,519,739 (38%) | 0% | 4.1 | 116,598 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 24 Nov 2025 | 28,096 | 2,529,739 (38%) | 0% | 4.1 | 116,598 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 24 Nov 2025 | 9,200 | 2,491,228 (38%) | 0% | 3.9 | 35,420 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 24 Nov 2025 | 9,200 | 2,501,228 (38%) | 0% | 3.9 | 35,420 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.13 per share. | 24 Nov 2025 | 1,489 | 2,482,028 (38%) | 0% | 4.1 | 6,150 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.13 per share. | 24 Nov 2025 | 1,489 | 2,492,028 (38%) | 0% | 4.1 | 6,150 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 24 Nov 2025 | 415 | 2,491,643 (38%) | 0% | 4.1 | 1,718 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 24 Nov 2025 | 415 | 2,501,643 (38%) | 0% | 4.1 | 1,718 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 21 Nov 2025 | 10,000 | 2,480,539 (38%) | 0% | 3.5 | 34,900 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 21 Nov 2025 | 10,000 | 2,490,539 (38%) | 0% | 3.5 | 35,000 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 14 Nov 2025 | 15,000 | 2,470,539 (37%) | 0% | 2.1 | 31,650 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 28 Oct 2025 | 975,610 | 2,455,539 (37%) | 14% | 2.1 | 2,000,001 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.30 per share. | 29 Aug 2025 | 5,000 | 1,479,929 (22%) | 0% | 2.3 | 11,500 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.29 per share. | 29 Aug 2025 | 5,000 | 1,474,929 (22%) | 0% | 2.3 | 11,450 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.28 per share. | 29 Aug 2025 | 5,000 | 1,469,929 (22%) | 0% | 2.3 | 11,400 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.60 per share. | 19 Aug 2025 | 6,717 | 1,453,001 (22%) | 0% | 2.6 | 17,464 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.58 per share. | 19 Aug 2025 | 5,545 | 1,463,829 (22%) | 0% | 2.6 | 14,306 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.59 per share. | 19 Aug 2025 | 5,283 | 1,458,284 (22%) | 0% | 2.6 | 13,683 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.57 per share. | 19 Aug 2025 | 1,100 | 1,464,929 (22%) | 0% | 2.6 | 2,827 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.80 per share. | 13 Jun 2025 | 25,000 | 1,446,283 (22%) | 0% | 2.8 | 70,000 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 13 Jun 2025 | 1 | 1,446,284 (22%) | 0% | 3 | 3 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 2.43 per share. | 29 May 2025 | 5,000 | 1,421,283 (21%) | 0% | 2.4 | 12,150 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 20 Nov 2023 | 163,880 | 223,357 (3%) | 2% | 6.1 | 999,668 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 29,600 | 29,600 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 12.61 per share. | 07 Apr 2023 | 59,477 | 59,477 (0%) | 0% | 12.6 | 750,005 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 6,820 | 6,820 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.39 per share. | 03 Jan 2022 | 30,000 | 1,415,889 (21%) | 0% | 4.4 | 131,700 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 9,000 | 9,000 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 7,142 | 0 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.25 per share. | 03 Jan 2022 | 7,142 | 1,416,373 (21%) | 0% | 0.3 | 1,786 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.78 per share. | 03 Jan 2022 | 6,658 | 1,409,231 (21%) | 0% | 19.8 | 131,695 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.78 per share. | 03 Jan 2022 | 90 | 1,416,283 (21%) | 0% | 19.8 | 1,780 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 4,500 | 4,500 | - | - | Stock Option (right to buy) |